Theraclion SA (EPA:ALTHE)

Market Cap	25.28M
Revenue (ttm)	830.21K
Net Income (ttm)	-5.76M
Shares Out	46.98M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38,591
Average Volume	156,149
Open	0.5740
Previous Close	0.5700
Day's Range	0.5260 - 0.5740
52-Week Range	0.1416 - 0.7960
Beta	-0.15
RSI	55.48
Earnings Date	Oct 29, 2025

About Regulus Therapeutics

Theraclion SA provides therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient’s skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 32
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALTHE

Financial Performance

In 2024, Theraclion's revenue was 830,209, a decrease of -54.44% compared to the previous year's 1.82 million. Losses were -5.76 million, 56.7% more than in 2023.